Clinical trial
Does Periarticular Injection (PAI) Reduce Pain After TKA Among Knee Arthroplasty Patients Receiving Adductor Canal Block and Infiltration Between the Popliteal Artery and the Capsule of the Posterior Knee (ACB&IPACK)? A Blinded, Randomized Controlled Trial.
NCT04749615 is registered in ClinicalTrials.gov with Hospital for Special Surgery, New York as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Does Periarticular Injection (PAI) Reduce Pain After TKA Among Knee Arthroplasty Patients Receiving Adductor Canal Block and Infiltration Between the Popliteal Artery and the Capsule of the Posterior Knee (ACB&IPACK)? A Blinded, Randomized Controlled Trial.
- Lead sponsor
- Hospital for Special Surgery, New York
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- December 17, 2020
- Completion date
- July 1, 2022
- Enrollment
- 94 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
total knee athroplasty